Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Inventory (2016 - 2025)

Angiodynamics (ANGO) has disclosed Inventory for 15 consecutive years, with $65.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory fell 0.53% year-over-year to $65.6 million, compared with a TTM value of $65.6 million through Nov 2025, down 0.53%, and an annual FY2025 reading of $62.0 million, up 2.29% over the prior year.
  • Inventory was $65.6 million for Q4 2025 at Angiodynamics, up from $62.3 million in the prior quarter.
  • Across five years, Inventory topped out at $65.9 million in Q4 2024 and bottomed at $48.0 million in Q1 2022.
  • Average Inventory over 5 years is $58.0 million, with a median of $60.3 million recorded in 2023.
  • The sharpest move saw Inventory dropped 18.85% in 2021, then skyrocketed 32.25% in 2023.
  • Year by year, Inventory stood at $48.2 million in 2021, then soared by 31.12% to $63.2 million in 2022, then rose by 1.7% to $64.3 million in 2023, then increased by 2.59% to $65.9 million in 2024, then dropped by 0.53% to $65.6 million in 2025.
  • Business Quant data shows Inventory for ANGO at $65.6 million in Q4 2025, $62.3 million in Q3 2025, and $62.0 million in Q2 2025.